ArticleCureus2025
Colon Metastasis From Primary Lung Cancer: A Report of a Rare Case and Review of Diagnostic and Therapeutic Challenges.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This case report aims to describe the rare occurrence of colon metastasis that originated from primary lung adenocarcinoma, highlighting the diagnostic challenges, therapeutic interventions, and clinical implications. A 62-year-old woman diagnosed with a biphenotypic lung carcinoma (squamous and adenocarcinomatous components) developed gastrointestinal (GI) symptoms. Imaging and endoscopic evaluation revealed a 3 cm sessile polypoid lesion in the ascending colon. Histopathological analysis and immunohistochemical profiling confirmed the lesion as a metastatic adenocarcinoma from the primary lung cancer. The patient underwent successful endoscopic mucosectomy with clear surgical margins, followed by targeted therapy with osimertinib due to the presence of an epidermal growth factor receptor (EGFR) mutation. Thus, this case underscores the necessity of considering metastatic lung cancer in the differential diagnosis of colonic lesions, particularly in patients with a known history of lung cancer. Comprehensive histopathological and immunohistochemical analyses are crucial for accurate diagnosis. The management of such rare metastases requires a multidisciplinary approach, integrating surgical and targeted therapies to improve patient outcomes. This report adds valuable insights into the clinical presentation, diagnostic processes, and therapeutic strategies for atypical metastatic patterns in lung cancer.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.